Phylos Overview

  • Status
  • Private
  • Employees
  • 28
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $7.6M
Latest Deal Amount
  • Investors
  • 12

Phylos General Information


Operator of an agricultural genomics company intended to enhance the next generation of hemp and cannabis. The company offers a suite of tools using modern molecular genetics and computational biology to provide breeding and research services, thereby enabling cannabis growers and cultivators to understand the breadth of genetics in their catalog, evaluate the development of additional varieties and drive business growth.

Contact Information

Formerly Known As
Phylos Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Agriculture
Primary Office
  • 959 South East Division Street
  • Suite 420
  • Portland, OR 97214
  • United States
+1 (503) 000-0000

Phylos Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phylos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Feb-2022 $7.6M 000.00 Completed Generating Revenue
8. Later Stage VC 04-May-2021 00.00 000.00 Completed Generating Revenue
7. Later Stage VC 26-Jan-2021 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series B1) 29-Apr-2020 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 15-Jan-2019 0000 000.00 0000 Completed Generating Revenue
4. Accelerator/Incubator 00.00 Completed Generating Revenue
3. Later Stage VC (Series B) 17-Jan-2014 000 00.00 00.00 Completed Generating Revenue
2. Early Stage VC (Series A1) 30-Mar-2011 $1000K $2.4M 000 Completed Startup
1. Early Stage VC (Series A) 14-Nov-2008 $1.4M $1.4M 00.00 Completed Startup
To view Phylos’s complete valuation and funding history, request access »

Phylos Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000 000.00 000.00 00 000.00 0.000
Series B 000,000 000.00 000.00 00 000.00 00.000
Series A1 109,811 $19.93 $19.93 1x $19.93 12.9%
Series A 355,716 $19.93 $19.93 $19.93 41.79%
To view Phylos’s complete cap table history, request access »

Phylos Patents

Phylos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200329658-A1 Hemp variety nbs cbd-1 Pending 21-Nov-2019 00000000

Phylos Executive Team (14)

Name Title Board Seat Contact Info
Ralph Risch Chief Executive Officer, Chief Operating Officer & Board Member
Dylan Anderson Co-Chief Financial Officer
Alisha Holloway Ph.D Chief Scientific Officer
Nishan Karassik Co-Founder, Chief Innovation Officer & Board Member
Barbara Mazur Ph.D Advisor
You’re viewing 5 of 14 executive team members. Get the full list »

Phylos Board Members (8)

Name Representing Role Since
David Patterson Phylos Board Member 000 0000
Lada Rasochova Ph.D Self Board Member & Advisor 000 0000
Mina Mishrikey Self Board Member 000 0000
Nishan Karassik Phylos Co-Founder, Chief Innovation Officer & Board Member 000 0000
Ralph Risch Phylos Chief Executive Officer, Chief Operating Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Phylos Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phylos Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accomplice VC Venture Capital Minority 000 0000 000000 0
Merida Capital Holdings Growth/Expansion Minority 000 0000 000000 0
Arcadian Capital Venture Capital Minority 000 0000 000000 0
Artemis Growth Partners Impact Investing Minority 000 0000 000000 0
Big Rock Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »